120 likes | 385 Views
CURRENT-OASIS 7. Objective: To assess the effect of various clopidogrel and aspirin regimens on major CV events and ST in ACS patients undergoing PCI. Study: Multicenter, randomized trial. 2 x 2 factorial design.
E N D
CURRENT-OASIS 7 Objective: To assess the effect of various clopidogrel and aspirin regimens on major CV events and ST in ACS patients undergoing PCI. Study: Multicenter, randomized trial. 2 x 2 factorial design. Population: ACS patients (STEMI, NSTEMI, unstable angina with ST depression). Endpoint: Composite of CV death, MI or stroke.
High dose aspirin N=6253 CAG PCI ≤ 72h Double + high N=4298 Double dose clopidogrel N=12520 Double + Low N=4262 Low dose aspirin N=6267 Randomized N=25086 High dose aspirin N=6254 Standard + High N=4326 Standard dose clopidogrel N=12566 Low dose aspirin N=6312 Standard + Low N=4376 No PCI N=7823 CURRENT-OASIS 7
CURRENT-OASIS 7 Event rate at 30 days (%) p=0.039 p=0.71 p=0.018 p<0.001 p=0.009
CURRENT-OASIS 7 p=0.76 p=0.35 p=0.80 p=0.62 p=0.22
CURRENT-OASIS 7 Conclusion: In patients undergoing PCI for ACS a 7 day double dose clopidogrelregimen was associated with a reduction in CV events and ST. No difference was found between high and low dose aspirin. Mehta et al. Lancet 2010;376:1233-43